Quality Initiative in Clinical Practice: A Single-Institution Appraisal of Quality Metrics in the Management of Newly Diagnosed Diffuse Large B-Cell Lymphoma
Objective: To assess our adherence to treatment guidelines for diffuse large B-cell lymphoma (DLBCL) established by the American Society of Hematology in 2014 through implementation of a quality improvement initiative (QII) at our institution in 2015. Patients and Methods: Patients with newly diagno...
Main Authors: | Alina M. Bischin, BA, Prakash Vishnu, MBBS, Ruqin Chen, MD, Kevin B. Knopf, MD, MPH, David M. Aboulafia, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-12-01
|
Series: | Mayo Clinic Proceedings: Innovations, Quality & Outcomes |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2542454819301122 |
Similar Items
-
Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma With MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review
by: Alina M Bischin, et al.
Published: (2017-02-01) -
AIDS-Related Non-Hodgkin's Lymphoma in the Era of Highly Active Antiretroviral Therapy
by: Prakash Vishnu, et al.
Published: (2012-01-01) -
Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapy
by: Tommy Sheu, MD, et al.
Published: (2018-10-01) -
Therapy of Newly Diagnosed Follicular Lymphoma
by: Jason R. Westin, et al.
Published: (2012-12-01) -
High Incidence of Antiphospholipid Antibodies in Newly Diagnosed Patients With Lymphoma and a Proposed aPL Predictive Score
by: Smith Kungwankiattichai MD, et al.
Published: (2020-07-01)